Cited by 1,075Toxic Organic Pollutants ImpactImmunotoxicology and immune responsesDrug-Induced Hepatotoxicity and Protection

Immune System Impairment and Hepatic Fibrosis in Mice Lacking the Dioxin-Binding Ah Receptor

Open access
Fernandez-Salguero, Pedro, Pineau, Thie, Hilbert, David M., McPhail, Timothy, Lee, Susanna S. T., Kimura, Shioko, Nebert, Daniel W., Rudikoff, Stuart +2 more·1995·Science

Abstract

The aryl hydrocarbon (Ah) receptor (AHR) mediates many carcinogenic and teratogenic effects of environmentally toxic chemicals such as dioxin. An AHR-deficient (Ahr -/- ) mouse line was constructed by homologous recombination in embryonic stem cells. Almost half of the mice died shortly after birth, whereas survivors reached maturity and were fertile. The Ahr -/- mice showed decreased accumulation of lymphocytes in the spleen and lymph nodes, but not in the thymus. The livers of Ahr -/- mice were reduced in size by 50 percent and showed bile duct fibrosis. Ahr -/- mice were also nonresponsive with regard to dioxin-mediated induction of genes encoding enzymes that catalyze the metabolism of foreign compounds. Thus, the AHR plays an important role in the development of the liver and the immune system.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/science.7732381

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Hepatic phenotypes, including reduced liver size, hepatic portal fibrosis, neonatal hepatic steatosis, and reduced hepatocyte size, were also observed in Ahr null mice.

    “Hepatic phenotypes, including reduced liver size, hepatic portal fibrosis, neonatal hepatic steatosis, and reduced hepatocyte size, were also observed (Fernandez-Salguero et al., 1995; Harstad et al., 2006).”

    From Rodent Genetic Models of Ah Receptor Signaling (2021) · cites this paper as Fernandez-Salguero et al., 1995

    The liver-comparison passage reports smaller livers and portal-tract fibrosis in Ahr-null mice, and the Fig. 2 caption describes small hepatocytes with little cytoplasm. Our copy does not report neonatal hepatic steatosis, so this source supports three of the four listed phenotypes. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • The generation of three independent Ahr null mouse models (AhrΔ1, AhrΔ2, and AhrLacZ) has revealed a significant role for the AHR in hepatic and vascular development as well as for the maintenance of barrier tissues and the immune system.

    “The generation of three independent Ahr null mouse models (AhrΔ1, AhrΔ2, and AhrLacZ) described in more detail below, has revealed a significant role for the AHR in hepatic and vascular development as well as for the maintenance of barrier tissues (e.g., intestine, skin, and lung) and the immune system (Fernandez-Salguero et al., 1995; Mimura et al., 1997; J. V. Schmidt et al., 1996).”

    From Rodent Genetic Models of Ah Receptor Signaling (2021) · cites this paper as Fernandez-Salguero et al., 1995

    The Ahr-deficient mouse-line description and the liver and immune-system findings support this paper's contribution to the cited sentence. The liver histology and immune-cell passages report hepatic fibrosis and reduced peripheral lymphocytes, but this paper describes one mouse line, not all three models; it does not establish vascular development or maintenance of barrier tissues. Its organ survey reports no obvious histological abnormalities in the intestine or lung (section labels: “Abstract,” “Ahr+I+ mice,” and organ comparison; page numbers unavailable). (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Genetic tools such as the Ahr null mouse model have revealed an essential role of AHR in normal physiology.

    “Genetic tools such as the Ahr null mouse model have revealed an essential role of AHR in normal physiology (Fernandez-Salguero et al., 1995; Mimura et al., 1997; J. V. Schmidt et al., 1996).”

    From Rodent Genetic Models of Ah Receptor Signaling (2021) · cites this paper as Fernandez-Salguero et al., 1995

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 27

  1. H. I. Swanson and C. A. Bradfield. Pharmacogenet ics 3, 213 (1993).
  2. E. C. Hoffman et al., Science 252, 954 (1991);
  3. H. Li, L. Dong, J. P. Whitlock Jr .• J. Biol. Chem. 269, 28098 (1994);
  4. M. L. Whitelaw, J.-A. Gustafsson, L. Poellinger, Mo/. Cell. Biol. 14, 8343 (1994).
  5. A. B. Okey, D. S. Riddick, P. A. Harper, Trends Phar macol. Sci. 15, 226 (1994).
  6. G. W. Lucier, C. J. Portier, M. A. Gallo, Environ. Health Perspect. 101, 36 (1993);
  7. M. J. DeVito, X. Ma, J. G. Babish, M. Menache, L. Birnbaum, Toxico/. Appl. Pharmacol. 124, 82 (1994);
  8. P. A. Bertazzi et al., Epidemiology 4, 398 (1993);
  9. L. S. Birnbaum, Environ. Health Perspect. 102, 676 (1994).
  10. D. J. Mcconkey, P. Hartzell, S. K. Duddy, H. Ha kansson, S. Orrenius, Science 242, 256 (1988).
  11. D. W. Nebert, CRC Grit. Rev. Toxicol. 20, 153 (1989).
  12. __ , D. D. Peterson, A. Puga, Pharmacogenetics 1, 68 (1991).
  13. W. U, S. Donat, 0. Dohr, K. Untried, J. Abel, Arch. Biochem. Biophys. 315, 279 (1994).
  14. K. M. Dolwick et al., Mo/. Pharmacol. 44, 911 (1993).
  15. S. Kimura, F. J. Gonzalez, D. W. Nebert, Mo/. Cell. Biol. 6, 1471 (1986).
  16. F. J. Gonzalez and D. W. Nebert, Nucleic Acids Res. 13, 7269 (1985).
  17. U. Savas et al., J. Biol. Chem. 269, 14905 (1994);
  18. Z. Shen et al., DNA Cell Biol. 13, 763 (1994).
  19. B. D. Abbott, G. H. Perdew, L. S. Birnbaum, Toxico/. Appl. Pharmacol. 126, 16 (1994);
  20. D. W. Nebert, Bio chem. Pharmacol. 47, 25 (1994).
  21. M. Capecchi, Science 244, 1288 (1989).
  22. S. L. Mansour et al., Nature 336, 348 (1988).
  23. F. J. Gonzalez, Pharmacol. Rev. 40, 243 (1989);
  24. J. 0. Miners and P. I. Mackenzie, Pharmacol. Ther. 51, 347 (1991).
  25. F. J. Gonzalez and D. W. Nebert, Trends Genet. 6, 182 (1990).
  26. S. Hayashi et al., Carcinogenesis 15, 801 (1994).
  27. A. Poland and J. C. Knutson, Annu. Rev. Pharmacol. Toxicol. 22, 517 (1982).

Cited by

Sorted by citations

Authors
Fernandez-Salguero, P., Pineau, T., Hilbert, D. M., McPhail, T., Lee, S. S. T., Kimura, S., Nebert, D. W., Rudikoff, S., Ward, J. M., & Gonzalez, F. J.
Affiliations
National Institutes of Health (US)
Venue
Science
Published
1995-05-05
Volume
268
Issue
5211
Pages
722-726
ISSN
  • 0036-8075 (ISSN-L)
  • 1095-9203
OpenAlex
W2091726431
Cited by
1,075
References
0
Citations by year
2026: 12 · 2025: 13 · 2024: 15 · 2023: 23 · 2022: 28 · 2021: 34 · 2020: 26 · 2019: 28 · 2018: 33 · 2017: 45 · 2016: 40 · 2015: 25 · 2014: 26 · 2013: 30 · 2012: 36
FWCI
56.29
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Science (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, cc-by-nc)
Funders
National Institute of Environmental Health Sciences (R01ES006811, P30ES006096)
Topics
  • Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Toxic Organic Pollutants Impact
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotoxicology and immune responses
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
Keywords
aryl hydrocarbon receptor, AhR knockout mice, immune system development, lymphocyte accumulation, liver fibrosis, bile duct fibrosis, dioxins, liver development, xenobiotic metabolism, embryonic lethality
MeSH terms
Animals, Female, Gene Expression Regulation, Immunity, Liver, Liver Cirrhosis, Experimental, Lymphoid Tissue, Male, Mice, Inbred C57BL, Receptors, Aryl Hydrocarbon, Mice, Knockout, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review